First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
First lead candidate to address a solid tumor indication with significant unmet medical need Supportive pre-clinical proof of concept data reported at SITC 2023 that demonstrated feasibility,...
Source: marketscreener.com